🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesGLP-1 and arterial inflammation — my results so far Page 3

GLP-1 and arterial inflammation — my results so far

InsuranceTom Sat, Aug 17, 2024 at 10:26 AM 13 replies 1,976 viewsPage 3 of 3
mike_mealprep
Member
412
1,890
Jul 2024
Chicago, IL
Aug 17, 2024 at 2:41 PM#11
sarah.morrison said:
GLP-1 and arterial inflammation my is not that straightforward in my experience

This is exactly right. sarah.morrison articulated what I have been trying to explain to my doctor for months. The GLP-1 and arterial aspect is the most important factor.

48 14mia_MS2, LeilaHI, marcus_mpls and 45 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Aug 17, 2024 at 2:58 PM#12

Reading this thread on GLP-1 and arterial hits close to home. Night shift nurse — I started at 287 lbs and felt like I would tried everything.

13 months on tirz and I am a different person. Not just the 62 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about GLP-1 and arterial — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Aug 17, 2024 at 3:58 PM
42 1traveltech_sara, AttorneyGrant, DebRD_ATL and 39 others
Reply Quote Save Share Report
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
Aug 17, 2024 at 3:15 PM#13

Dr.NephBHM_UK — that is really helpful context on GLP-1 and arterial. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

28 21SleepFixSam, PurityPaulOR, MaxMetOK and 25 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Aug 17, 2024 at 3:32 PM#14

To answer Dr.PulmRoch's question specifically:

From a clinical standpoint, GLP-1 and arterial is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

29 14Dr.PeteFamMed, claudia_zurich, nancy_portland and 26 others
Reply Quote Save Share Report
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Aug 17, 2024 at 3:49 PM#15

Bookmarked 📌 The GLP-1 and arterial info in this thread is essential. Coming back to this for sure.

Last edited: Aug 17, 2024 at 7:49 PM
23 1cory_ATX, lori_vegas, Dr.PulmRoch and 20 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register